Par Drugs and Chemicals Reports Q2 FY27 Results
Par Drugs and Chemicals Ltd · Outcome · 29 Oct 2026, 10:37 pm
Par Drugs and Chemicals Reports Q2 FY27 Results Par Drugs and Chemicals reported revenue from operations of ₹2,743.19 lakhs for the quarter ended 30th Sep'26, down 4.28% YoY from ₹2,865.89 lakhs and 12.30% QoQ from ₹3,128.05 lakhs. Net profit declined 36.36% YoY to ₹262.80 lakhs compared to ₹412.96 lakhs in Q2 FY26 and ₹471.27 lakhs in Q1 FY27. Quarterly basic and diluted EPS stood at ₹2.14 versus ₹3.36 in the previous year. For the half-year ended 30th Sep'26, revenue rose 7.33% YoY to ₹5,871.24 lakhs, while net profit dropped slightly to ₹734.07 lakhs.
Original exchange filing (PDF)
More announcements from Par Drugs and Chemicals Ltd
- Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on October 29, 2026. · 29 Oct 2026
- Par Drugs And Chemicals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 29 Oct 2026
- PAR DRUGS AND CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 29-Oct-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 29 Oct 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters · 29 Oct 2026
- Par Drugs And Chemicals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 26, 2026. Further, the company has informed the Exchange regarding voting results. · 27 Sept 2026
- Par Drugs And Chemicals Limited has informed the Exchange regarding 'Proceeding of AGM dated 26.09.2026'. · 26 Sept 2026
- Par Drugs And Chemicals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 26, 2026 · 26 Sept 2026
- Par Drugs And Chemicals Limited has informed the Exchange regarding 'Regulation 36 (1)(b)'. · 01 Sept 2026
